Express Pharma

US FDA declines to approve AstraZeneca treatment for chronic nasal condition

The drugmaker said the US Food and Drug Administration (FDA) had issued a complete response letter following AstraZeneca's application to extend use of the treatment and requested additional clinical data from it

0 206